India's Alembic Pharmaceuticals (ALEM.NS) on Tuesday reported a 12.1% increase in first-quarter profit, driven by strong demand for generic drugs in its key U.S. market.
($1 = 95.3800 Indian rupees)
Financetime
© Financetime.org 2026.
All rights reserved.
Hosted by LeadsDeposit.com
Produced by
C-iT